ASMLs, Diplomatic

ASML's Diplomatic Tightrope Walk and the Memory Money Wave Collide Ahead of July 15

Published on 07/06/2026 at 05:53 | Redaktion boerse-global.de

ASML shares rally ahead of July 15 earnings, fueled by memory chip investments from Micron, Samsung, and SK Hynix, even as Dutch trade mission to China faces export control complications.

ASML Stock Surges 65% in 2024 Amid China Export Tensions and $520B Memory Boom
ASML's Diplomatic Tightrope Walk and the Memory Money Wave Collide Ahead of July 15 Illustration mit AI erstellt übermittelt durch boerse-global.de

The contrast could hardly be starker. As a delegation of Dutch business leaders — including senior figures from ASML and NXP — prepares to fly to Peking for talks with China’s top trade officials, the semiconductor equipment maker finds itself riding a $520 billion memory chip investment boom on the other side of the world. The two forces are colliding in a single stock that has already surged 65% this year and now faces a pivotal earnings report on July 15.

The four-day mission, which starts July 6 under Dutch trade minister Sjoerd Sjoerdsma, will take the group to Peking and Shanghai. Sjoerdsma, only recently removed from Beijing’s sanctions list, is scheduled to meet China’s commerce minister Wang Wentao and Shanghai party secretary Chen Jining. Yet the trip is shadowed by a condition: participating executives have reportedly demanded that the minister steer clear of human rights issues and arms sales to Taiwan during his meetings. Many Dutch companies initially hesitated to join, fearing precisely those politically explosive topics would derail business discussions.

Just days before the delegation’s departure, the Netherlands formally joined the US-led Pax Silica chip and AI alliance — a move that tightens multilateral export controls and complicates the very negotiations Sjoerdsma will now attempt in China. The timing is awkward because the Dutch government had lobbied hard in Washington to block a proposed US law that would allow American authorities to veto sales of certain ASML lithography machines to China. Those mid-range tools, which are not the most advanced but still critical, account for roughly a fifth of ASML’s expected revenue this year, according to the Financieele Dagblad. The company’s top-end High-NA EUV systems have been off-limits to China since 2019.

Against this geopolitical crosscurrent, the stock has shown remarkable resilience. ASML closed at €1,628.00 on Friday, a near-5% single-day rebound from a mid-week selloff sparked by the Pax Silica news. That recovery was part of a broader risk-on move driven by weaker-than-expected US June jobs data. Still, the share sits about 7% below its 52-week high of €1,748.00, set just on June 30. The annualized 30-day volatility has jumped to nearly 63%, reflecting how sensitively the equity reacts to every new headline on export curbs.

Should investors sell immediately? Or is it worth buying Asml?

Why the Memory Boom Matters More Than the Export Spat Right Now

The real engine behind ASML’s recent rally — a 24.3% jump in June alone without any company-specific financial releases — came from Asia. Micron dramatically beat earnings expectations on June 24 and raised its fiscal-year capex to $27 billion from a previously stated $25 billion. South Korea’s Samsung and SK Hynix jointly announced a colossal $520 billion multi-year plan to build new memory chip fabs. Since virtually all major memory producers rely on ASML’s EUV lithography tools to manufacture high-bandwidth memory used in AI accelerators, those investment pledges are a direct tailwind for future order intake.

That momentum is now colliding with the diplomatic friction in the short term. Analysts remain overwhelmingly bullish. UBS raised its price target from €1,900 to €2,100 with a Buy rating; Wells Fargo increased its target from $1,750 to $2,200, also Overweight; BofA lifted its target from $2,268 to $2,345, maintaining Buy. Barclays kept a Buy rating. The consensus view is that ASML’s order book for 2027 is already fully filled, and that the real earnings acceleration will hit in 2027–2028, not in the next few quarters.

Valuation Signals a Premium That Needs Justification

The stock’s trailing price-to-earnings ratio of around 62.8 sits just below the semiconductor industry average of 65.7, but well above a model-derived fair P/E of approximately 52.9. That implies a premium that investors are paying for future growth that is not yet reflected in current earnings. On a broad value score, ASML earns only 2 out of 6 points, highlighting the aggressive growth expectations baked into the price.

Technically, the shares remain firmly above their moving averages: 12.86% above the 50-day line at €1,442.48 and 41.73% above the 200-day line at €1,148.68. The relative strength index of 54.6 suggests there is room for further upside before overheating, but a weak order intake or cautious guidance on July 15 could easily snap the momentum and send the stock retreating toward the 200-day support.

Asml at a turning point? This analysis reveals what investors need to know now.

July 15: The Report That Will Weigh Diplomacy Against Orders

All eyes are now on Wednesday, July 15, when ASML reports second-quarter results before the market opens. BofA expects the report will confirm that the 2027 order book is fully loaded, but the market will scrutinise new order trends amid the uncertainty around export controls and the potential impact of the US law Washington is still pushing. ASML’s full-year 2026 revenue guidance — €36 billion to €40 billion — will also be in the spotlight.

As Sjoerdsma’s delegation flies to Peking, the outcome of those talks could either soothe investors or amplify their anxieties. With ASML accounting for 14.69% of the AEX index, any negative surprise on July 15 would ripple well beyond a single stock. For now, the market is betting that the memory money wave outweighs the diplomatic drama — but that bet will be tested very soon.

Ad

Asml Stock: New Analysis - 6 July

Fresh Asml information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Asml analysis...

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | NL0010273215 | ASMLS | boerse | 69701200 |